1. Sikora K. Paying for cancer care—a new dilemma. J R Soc Med. 2007;100(4):166–9.
2. Kelly C, Mir F. Biological therapies: how can we afford them? BMJ. 2009;339(7722):666–9.
3. Aulton ME. Aulton’s pharmaceutics: the design and manufacture of medicines. 3rd ed. New York: Churchill Livingstone Elsevier; 2007.
4. Speers M, Bonnano C. Economic aspects of controlled drug delivery. In: Mathiowitz E, editor. Encyclopaedia of controlled drug delivery. 1st ed. New York: Wiley Interscience; 1999. p. 341–7.
5. UK Hospital and Community Health Services. HCHS pay and prices series 2010–2011. http://www.info.doh.gov.uk/doh/finmannsf/af3d43e36a4c8f8500256722005b77f8/276315c0677bf5478025796b00418a4d?OpenDocument . Accessed 15 Nov 2012.